TTAB Oppositions 91189293
USPTO Oppositions proceeding 91189293, filed 2009-03-16. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91189293 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2009-03-16 |
| Last Activity | 2009-06-25 |
| Days Active | 6269 |
Parties
- Kiel Laboratories, Inc. — Defendant
- Jazz Pharmaceuticals, Inc., JPI Commercial, LLC — Plaintiff
Plaintiff Marks
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM PATIENT SUCCESS PROGRAM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM SUCCESS PROGRAM — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
- XYREM SUCCESS PROGRAM FOR PHYSICIANS — Jazz Pharmaceuticals, Inc., JPI Commercial, LLC
Defendant Marks
- ZYTAN — Kiel Laboratories, Inc.
Recent Documents
- 2009-06-25: TERMINATED — Status
- 2009-06-25: BOARD'S DECISION: SUSTAINED — Decisions
- 2009-06-25: WITHDRAWAL OF APPLICATION — Withdrawals
- 2009-04-20: ANSWER — Pleadings
- 2009-03-16: PENDING, INSTITUTED — Status
- 2009-03-16: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2009-03-16: FILED AND FEE — Fees